首页 / 院系成果 / 成果详情页

The Evaluation of Colorectal Cancer Risk in Serum by anti-DESMIN-conjugated CdTe/CdS Quantum Dots  期刊论文  

  • 编号:
    5185790a-9801-4412-8b0c-fa6288253b00
  • 作者:
    Wang, Yao[1] Li, Yuanting[2] Chen, Zhiyong[1] Wang, Tianhao[3] Gu, Jie[3] Wu, Xianhua[3] Yin, Yi[1] Wang, Maosheng[1] Pan, Zhigang[3]
  • 语种:
    English
  • 期刊:
    CLINICAL LABORATORY ISSN:1433-6510 2017 年 63 卷 3 期 (579 - 586)
  • 收录:
  • 关键词:
  • 摘要:

    Background: DESMIN is a novel prognostic predictor and therapeutic target for colorectal cancer (CRC). Enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence (ELC) assays are large-scale and high cost projects; therefore, it is necessary to develop a new, fast, and simple yet highly sensitive and specific method to detect DESMIN in serum. Semiconducting quantum dots (QDs) possess high fluorescence quantum yield, stability against photobleaching, and size-controlled luminescence properties, thus being utilized in photoelectrochemical tumor marker detection, especially in ameliorating the diagnostic value in complex biological ambient ionization. However, CdTe/CdS quantum dots (QDs) have not been applied in detecting DESMIN in serum. Methods: DESMIN in serum has been established using anti-DESMIN-conjugated CdTe/CdS quantum dots (QDs) and measurements. The assay sensitivity was determined by measurement of quenched fluorescence intensity of DESMIN at 0.1, 0.5, 1.0, 2.0, or 5.0 ng/mL in PBS or 0.25%, 0.5%, 1.0%, 2.0%, or 5% human serum diluted in PBS. The assay was optimized under different pH (7.00 - 7.40) for different reaction durations (10 - 60 minutes). The specificity of anti-DESMIN-QDs was determined by testing the interference of DESMIN activity with CEA, IgG, or AFP, each at 1 ng/mL. Results: Under the optimized incubation time (30 minutes) at room temperature and optimal pH 7.1 - 7.2, a correlation between the decreased fluorescence intensity of anti-DESMIN-conjugated CdTe/CdS QDs and the concentration of DESMIN in the range from 0.05 to 100 ng/mL, was established. The sensitivity for the detection of DESMIN in the range from 0.05 to 100 ng/mL, with a detection limit of 0.02 ng/mL. The assay presented a high specificity because the anti-DESMIN-conjugated CdTe/CdS QDs only reacted with ABR1B10 in the sera in the presence of CEA, IgG or AFP. Conclusions: The immunofluorescence assay to detect DESMIN in serum using anti-DEMSIN-conjugated CdTe/CdS QDs was fast and simple yet presented high sensitivity and specificity. Our method provides a promising tool for early prediction of CRC risk.

  • 推荐引用方式
    GB/T 7714:
    Wang Yao,Li Yuanting,Chen Zhiyong, et al. The Evaluation of Colorectal Cancer Risk in Serum by anti-DESMIN-conjugated CdTe/CdS Quantum Dots [J].CLINICAL LABORATORY,2017,63(3):579-586.
  • APA:
    Wang Yao,Li Yuanting,Chen Zhiyong,Wang Tianhao,&Pan Zhigang.(2017).The Evaluation of Colorectal Cancer Risk in Serum by anti-DESMIN-conjugated CdTe/CdS Quantum Dots .CLINICAL LABORATORY,63(3):579-586.
  • MLA:
    Wang Yao, et al. "The Evaluation of Colorectal Cancer Risk in Serum by anti-DESMIN-conjugated CdTe/CdS Quantum Dots" .CLINICAL LABORATORY 63,3(2017):579-586.
浏览次数:5 下载次数:0
浏览次数:5
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部